Home LiteratureArticle Details
PMID: 16166416 Published · ppublish English Comparative Study Journal Article

Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.

Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ

Abstract

The presence of similar histologic subtypes of epithelial ovarian and endometrial cancers has long been noted, although the relevance of this finding to pathogenesis and clinical management is unclear. Despite similar clinical characteristics, histologic subtypes of cancers of the ovary and endometrium are treated according to organ of origin. This study compares the gene expression profiles of analogous histologic subtypes of cancers of the ovary and endometrium using the same genomic platform to determine the similarities and differences between these tumors. Gene expression profiles of 75 cancers (endometrioid, serous, and clear cell) of the ovary and endometrium, five renal clear cell cancers, and seven normal epithelial brushings were determined using a 11,000-element cDNA array. All images were analyzed using BRB ArrayTools. Validation was done using real-time PCR on select genes and immunohistochemical staining. Comparison across endometrial and ovarian cancers and serous and endometrioid tumors showed expression patterns reflecting their organ of origin. Clear cell tumors, however, showed remarkably similar expression patterns regardless of their origin, even when compared with renal clear cell samples. A set of 43 genes was common to comparisons of each of the three histologic subtypes of ovarian cancer with normal ovarian surface epithelium. The comparison of the gene expression profiles of endometrioid and serous subtypes of ovarian and endometrial cancer are largely unique to the combination of a particular subtype in a specific organ. In contrast, clear cell cancers show a remarkable similarity in gene expression profiles across organs (including kidney) and could not be statistically distinguished.

MeSH Terms
Adenocarcinoma, Clear Cell/genetics,metabolism Carcinoma, Endometrioid/genetics,metabolism Carcinoma, Renal Cell/genetics,metabolism Cluster Analysis Cystadenocarcinoma, Serous/genetics,metabolism Endometrial Neoplasms/genetics,metabolism Female Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Kidney Neoplasms/genetics,metabolism Oligonucleotide Array Sequence Analysis/methods Ovarian Neoplasms/genetics,metabolism Tumor Suppressor Protein p53/analysis
Chemicals
Tumor Suppressor Protein p53
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Zorn Kristin K
National Cancer Institute, Bethesda, MD 20892, USA.
Bonome Tomas
Gangi Lisa
Chandramouli Gadisetti V R
Awtrey Christopher S
Gardner Ginger J
Barrett J Carl
Boyd Jeff
Birrer Michael J
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Published
2005-09-15
Pages
6422-30
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com